TIS tissue therapies limited

brw and naos asset management

  1. 4,709 Posts.
    lightbulb Created with Sketch. 77
    The Featherstone column of BRW magazine asked Sebastian Evans of NAOS Asset Management for his best three small biotech investments. He lists TIS, PAB and Phylogica.

    BRW weekly 15-21 Sept edition pages 54-55, Value in Biotechs.

    He says the X factor = Rapid revenue growth from 2013.

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.